Hot-melt extrusion (HME) is a leading approach to producing amorphous solid dispersions to increase solubility and bioavailability of promising drug compounds. HME technology offers numerous advantages, including well-defined process understanding, small equipment footprint, efficient (continuous) operation, and ready scalability. This technical brief describes Lonza's depth of experience with HME formulation and processing and its broad production capabilities in this important technology area. To learn more, please see our technical brief.
You may also be interested in:
View our technical brief
Latest briefing from the Knowledge Center
Unveiling Consumer Preferences for Oral Solid Dosage Forms. Capsules in the Spotlight
The article "Unveiling Consumer Preferences for Oral Solid Dosage Forms. Capsules in the Spotlight"...
Straight to Market in an Autoinjector
A smart, data-driven approach to formulate biotherapeutics for PFS with confidence The global...
GS Effex® Cell Line for Enhanced Antibody Effector Function
GS Effex® derived from Lonza's leading GS Xceed® cell line, has been engineered to lack the enzyme...
GS Xceed® Gene Expression System Brochure
GS Xceed® is a scalable, integrated, proven platform for developing biotherapeutics. The system is...
Early Solid Form Screening: A Case Study
Solid form screening is highly customizable based on the phase of the drug development life cycle,...
Accelerating Small Molecule Advancements
The increasing number of breakthroughs in small molecule drug development are exciting, but...
Cis-targeted Immunotherapies Need Large CDMO Expertise but also Flexibility
Asher Biotherapeutics is developing a pipeline of cis-targeted immunotherapies that selectively...
Transparent Communication Supports Tech Transfers of Cis-targeted Immunotherapies
Asher Biotherapeutics embarked on a search for a contract development and manufacturing organization...
Rapid and Material-Sparing Feasibility Screening for Hot Melt Extrusion
Amorphous solid dispersions (ASD) offer a bioavailability enhancement drug delivery solution for...
Meeting the Challenge of Rising API Complexity
The complexity of small molecule active pharmaceutical ingredients (APIs) is rising, bringing longer...
Impact of Process Re-design on Sustainability in Pharmaceutical Small Molecule Manufacturing
A recent study revealed, that the pharmaceutical industry is significantly more emission-intensive...